Solventum Revenue 2023-2025 | SOLV

Solventum annual/quarterly revenue history and growth rate from 2023 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Solventum revenue for the quarter ending March 31, 2025 was $2.070B, a 2.68% increase year-over-year.
  • Solventum revenue for the twelve months ending March 31, 2025 was $8.308B, a 1.29% increase year-over-year.
  • Solventum annual revenue for 2024 was $8.254B, a 0.7% increase from 2023.
  • Solventum annual revenue for 2023 was $8.197B, a 0.82% increase from 2022.
  • Solventum annual revenue for 2022 was $8.13B, a 0% decline from .
Solventum Annual Revenue
(Millions of US $)
2024 $8,254
2023 $8,197
2022 $8,130
Solventum Quarterly Revenue
(Millions of US $)
2025-03-31 $2,070
2024-12-31 $2,075
2024-09-30 $2,082
2024-06-30 $2,081
2024-03-31 $2,016
2023-12-31 $2,036
2023-09-30 $2,074
2023-06-30 $2,076
2023-03-31 $2,011
2022-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $12.853B $8.254B
Solventum is an independent healthcare company. Its business segment includes Medical Surgical, Dental Solutions, Health Information Systems and Purification and Filtration. Solventum is based in ST. PAUL, Minn.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $146.784B 27.53
Elevance Health (ELV) United States $87.260B 11.26
CVS Health (CVS) United States $83.934B 10.43
Cencora (COR) United States $57.186B 19.90
Natera (NTRA) United States $22.441B 0.00
DiDi Global (DIDIY) China $22.121B 23.50
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.895B 0.00
ICON (ICLR) Ireland $11.879B 11.04
CochLear (CHEOY) Australia $11.671B 0.00
Revvity (RVTY) United States $11.280B 19.41
Doximity (DOCS) United States $10.697B 49.52
Viatris (VTRS) United States $10.669B 3.67
Avantor (AVTR) United States $9.227B 13.41
HealthEquity (HQY) United States $8.993B 39.39
Medpace Holdings (MEDP) United States $8.737B 23.21
Sonic Healthcare (SKHHY) Australia $8.503B 0.00
Charles River Laboratories (CRL) United States $7.460B 14.62
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.400B 25.92
BrightSpring Health Services (BTSG) United States $3.797B 34.84
Sotera Health (SHC) United States $3.335B 18.95
Alignment Healthcare (ALHC) United States $2.983B 0.00
Surgery Partners (SGRY) United States $2.961B 38.50
Concentras Parent (CON) United States $2.793B 16.14
Organon (OGN) United States $2.618B 2.78
Ardent Health (ARDT) United States $1.938B 8.26
GeneDx Holdings (WGS) United States $1.894B 72.93
Premier (PINC) United States $1.855B 14.08
Progyny (PGNY) United States $1.847B 40.66
PACS (PACS) United States $1.614B 0.00
GoodRx Holdings (GDRX) United States $1.600B 32.00
Teladoc Health (TDOC) United States $1.258B 0.00
Pediatrix Medical (MD) United States $1.224B 9.31
Establishment Labs Holdings (ESTA) $1.073B 0.00
CareDx (CDNA) United States $1.048B 16.37
Ryman Healthcare (RYHTY) New Zealand $1.011B 0.00
Agilon Health (AGL) United States $0.907B 0.00
AMN Healthcare Services Inc (AMN) United States $0.828B 7.75
QDM (QDMI) Hong Kong, SAR China $0.763B 0.00
Nutex Health (NUTX) United States $0.694B 10.51
Embecta (EMBC) United States $0.587B 3.95
LifeMD (LFMD) United States $0.577B 0.00
Enhabit (EHAB) United States $0.505B 41.54
InnovAge Holding (INNV) United States $0.498B 0.00
Auna S.A (AUNA) Luxembourg $0.469B 10.57
Sonida Senior Living (SNDA) United States $0.467B 0.00
SBC Medicals (SBC) United States $0.464B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.423B 0.00
Performant Healthcare (PHLT) United States $0.257B 0.00
Oncology Institute (TOI) United States $0.236B 0.00
Beauty Health (SKIN) United States $0.197B 0.00
DocGo (DCGO) United States $0.154B 25.17
KindlyMD (KDLY) United States $0.150B 0.00
Pheton Holdings (PTHL) China $0.111B 0.00
KindlyMD (NAKA) United States $0.102B 0.00
So-Young (SY) China $0.095B 0.00
Basel Medical Group (BMGL) Singapore $0.087B 0.00
OncoCyte (OCX) United States $0.077B 0.00
Sera Prognostics (SERA) United States $0.067B 0.00
Ascend Wellness Holdings (AAWH) United States $0.063B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.055B 0.00
ModivCare (MODV) United States $0.048B 0.00
Biodesix (BDSX) United States $0.044B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.029B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00